BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 15999036)

  • 1. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial.
    Murphy GJ; Rogers CS; Lansdowne WB; Channon I; Alwair H; Cohen A; Caputo M; Angelini GD
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):20-8. PubMed ID: 15999036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial.
    Murphy GJ; Allen SM; Unsworth-White J; Lewis CT; Dalrymple-Hay MJ
    Ann Thorac Surg; 2004 May; 77(5):1553-9. PubMed ID: 15111142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting.
    Murphy GJ; Mango E; Lucchetti V; Battaglia F; Catapano D; Rogers CA; Angelini GD
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):475-80, 480.e1-8. PubMed ID: 16935098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
    Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
    Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET).
    Bednar F; Osmancik P; Vanek T; Mocikova H; Jares M; Straka Z; Widimsky P
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1054-60. PubMed ID: 18954649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison of autologous transfusion procedures in hip surgery].
    Lorentz A; Osswald PM; Schilling M; Jani L
    Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting.
    Parolari A; Mussoni L; Frigerio M; Naliato M; Alamanni F; Polvani GL; Agrifoglio M; Veglia F; Tremoli E; Biglioli P; Camera M
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1561-6. PubMed ID: 16307999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
    Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell saver does not increase pro-inflammatory cytokine levels and expression of adhesive molecules in the salvaged blood of patients undergoing off-pump coronary artery bypass surgery.
    Lin TY; Chen Y; Chiu KM; Lu CW; Jean WH; Horng FM; Chu SH
    Acta Anaesthesiol Taiwan; 2005 Dec; 43(4):211-5. PubMed ID: 16450595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
    Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.
    Vedin J; Antovic A; Ericsson A; Vaage J
    Ann Thorac Surg; 2005 Aug; 80(2):586-93. PubMed ID: 16039210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial.
    Goel P; Pannu H; Mohan D; Arora R
    Transfus Med; 2007 Aug; 17(4):285-9. PubMed ID: 17680954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study.
    Weltert L; D'Alessandro S; Nardella S; Girola F; Bellisario A; Maselli D; De Paulis R
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):621-6; discussion 626-7. PubMed ID: 20042202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of body core temperature on blood loss and transfusion requirements during off-pump coronary artery bypass grafting: a comparison of 3 warming systems.
    Hofer CK; Worn M; Tavakoli R; Sander L; Maloigne M; Klaghofer R; Zollinger A
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):838-43. PubMed ID: 15821652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.
    Paulitsch FS; Schneider D; Sobel BE; Rached R; Ramires J; Jatene F; Stolf N; Hueb W; Lopes NH
    Coron Artery Dis; 2009 Mar; 20(2):100-5. PubMed ID: 19293667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.